Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
Clinical trial NCT00024661 · COMPLETED
Trial details
- NCT number
- NCT00024661
- Sponsor
- INSYS Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.